ERYTECH welcomes new US and European investors Post author:admERY Post published:February 13, 2014 Post category:Newsroom ERYTECH was informed today that certain of its historical institutional investors have sold part of their holdings to new specialized life sciences investors in the United States and in Europe. You Might Also Like ERYTECH engages in collaborative partnership with EU Horizon 2020 EVIDENCE consortium May 5, 2020 ERYTECH Files Registration Statement for Proposed Initial Public Offering in the United States October 6, 2017 ERYTECH reports positive top-line Phase III results from clinical study with GRASPA® in Acute Lymphoblastic Leukemia September 30, 2014
ERYTECH Files Registration Statement for Proposed Initial Public Offering in the United States October 6, 2017
ERYTECH reports positive top-line Phase III results from clinical study with GRASPA® in Acute Lymphoblastic Leukemia September 30, 2014